Difference between revisions of "Team:San Andres/Software"

 
(29 intermediate revisions by the same user not shown)
Line 2: Line 2:
  
 
<head data-gwd-animation-mode="quickMode">
 
<head data-gwd-animation-mode="quickMode">
 +
  <title>&lt;endnote&gt;&lt;head&gt; &lt;title&gt;&lt;endnote&gt;&lt;head&gt; &lt;meta&gt; &lt;title&gt;
 +
  </title>
 +
</head>
 +
 +
<body>
 
   <title>wiki</title>
 
   <title>wiki</title>
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
Line 14: Line 19:
 
       -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
 
       -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
−
       background-color: transparent;
+
      background-image: url(https://static.igem.org/mediawiki/2015/8/8a/BBD7.jpg);
 +
       background-color: rgb(198, 169, 117);
 
     }
 
     }
 
   </style>
 
   </style>
−
</head>
+
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
−
 
+
  <title></title>
−
<body class="gwd-body-kwce">
+
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 +
  <title></title>
 +
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 +
  <title></title>
 
   <title>wiki</title>
 
   <title>wiki</title>
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
Line 143: Line 152:
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
 
       background-color: transparent;
 
       background-color: transparent;
 +
    }
 +
    .gwd-table-nb4m {
 +
      font-size: 24px;
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 +
      background-image: none;
 +
      background-color: rgb(255, 255, 255);
 
     }
 
     }
 
     .gwd-td-b6db {
 
     .gwd-td-b6db {
Line 523: Line 539:
 
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1);
 
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1);
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
−
    }
 
−
    .gwd-img-l2p5 {
 
−
      position: absolute;
 
−
      width: 135px;
 
−
      left: -160px;
 
−
      top: 26px;
 
 
     }
 
     }
 
     .gwd-img-n53q {
 
     .gwd-img-n53q {
Line 549: Line 559:
 
     }
 
     }
 
     .gwd-a-36ww {
 
     .gwd-a-36ww {
−
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
+
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, -16.1, 0.05, 0, 1);
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
 
     }
 
     }
Line 560: Line 570:
 
       top: 349.384236453212px;
 
       top: 349.384236453212px;
 
       width: 250px;
 
       width: 250px;
 +
    }
 +
    .gwd-img-zpsn {
 +
      position: absolute;
 +
      width: 150px;
 +
      left: -165.73913043478px;
 +
      top: 49.3260869565235px;
 +
    }
 +
    .gwd-a-d01x {
 +
      -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
 +
      -webkit-transform-style: preserve-3d;
 +
    }
 +
    .gwd-table-10nh {
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 +
    }
 +
    .gwd-table-15ao {
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 
     }
 
     }
 
   </style>
 
   </style>
 
   <!--navigation menu -->
 
   <!--navigation menu -->
 
   <br>
 
   <br>
 +
  <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-15ao">
 +
    <tbody>
 +
      <tr heigth="15px">
 +
      </tr>
 +
      <tr heigth="75px">
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres" style="color: rgb(0, 0, 0);">Home </a>
 +
        </td>
 +
        <td style="border: 3px solid black;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Team" style="color: rgb(0, 0, 0);"> Team</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Description" style="color: rgb(0, 0, 0);"> Project</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Parts" style="color: rgb(0, 0, 0);"> Parts</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Modeling" style="color: rgb(0, 0, 0);"> Modeling</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><a href="https://2015.igem.org/Team:San_Andres/Results" style="color: rgb(0, 0, 0);"> Results</a>
 +
        </td>
 +
      </tr>
 +
    </tbody>
 +
  </table>
 +
  <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-10nh">
 +
    <tbody>
 +
      <tr heigth="15px">
 +
      </tr>
 +
      <tr heigth="75px">
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Notebook" style="color: rgb(0, 0, 0);">Notebook</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Practices" style="color: rgb(0, 0, 0);"> Human Practices</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Design" style="color: rgb(0, 0, 0);"> Future Projections</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Attributions" style="color: rgb(0, 0, 0);"> Attributions</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Collaborations" style="color: rgb(0, 0, 0);"> Collaborations</a>
 +
        </td>
 +
      </tr>
 +
    </tbody>
 +
  </table>
 
   <div class="gwd-div-2ed9"></div>
 
   <div class="gwd-div-2ed9"></div>
 
   <div class="gwd-div-7xzo gwd-a-1thu">
 
   <div class="gwd-div-7xzo gwd-a-1thu">
−
     <h1>Future Projections&nbsp;</h1>
+
     <h1>Abstract</h1>
−
     <big>If our results are the expected our future projections are
+
     <div style="text-align: justify;"><big>The celiac
−
the following:<br>
+
disease affects 1 in 265 people worldwide and 15%
 +
of population in Chile. This in an irreversible autoimmune disease in
 +
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
 +
affected, the consumption of foods containing gluten (all fods derived
 +
from wheat, barley, rye, etc.) cause an inflammation in small intestine
 +
causing multiple effects in the organism (diarrhea, constipation, porr
 +
absorption, among others) significantly affecting their quatily of life.</big>
 +
      <br>
 +
      <br>
 +
      <big>Whereas the majority of the world food contains gluten, we
 +
propose a
 +
treatment for those who can't eat gluten, and can do so without
 +
problems. In detail, our project involves a system able to degrade
 +
gluten via the enzyme KumaMax and report the operation simultaneously
 +
with a red fluorescent protein. The foregoing, works in a genetically
 +
modified E. coli bacteria. With this project, in long run, we hope to
 +
improve the quality of life of all those reported with celiac disease.
 +
People who suffer from gluten intolerance have an adverse reaction to
 +
gluten proteins found in wheat, barley, and rye products.</big>
 +
      <br>
 +
    </div>
 +
    <big><br>
 
</big>
 
</big>
−
    <ul>
 
−
      <li><big>Be one of the first Latin American teams at the
 
−
school level in the IGEM competition.</big>
 
−
      </li>
 
−
      <li><big>Disclosure to the scientific community.</big>
 
−
      </li>
 
−
      <li><big>Realize workshops in academic institutions of
 
−
this enteropathy with the aim of being more known in society.</big>
 
−
      </li>
 
−
      <li><big>Generate the product and market it for
 
−
therapeutic purposes.</big>
 
−
      </li>
 
−
    </ul>
 
 
     <div style="text-align: center;">
 
     <div style="text-align: center;">
−
       <img src="https://static.igem.org/mediawiki/2015/3/3f/Igem.png" alt="igem.png" title="igem.png" style="width: 649px; height: 262px;">
+
       <img style="width: 893px; height: 373px;" alt="File:Ex 2.jpg" src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg">
−
      <br>
+
−
      <br>
+
−
      <h1 style="text-align: left;">Business Model</h1>
+
−
      <div style="text-align: left;"><big>If all goes
+
−
well, we going to patenting our pill, which give us licenses which we
+
−
can sell to pharmacies and laboratories to produce the medication and
+
−
sell it to celiac patients. This would mean a social benefit and an
+
−
benefict for us.</big>
+
−
        <br>
+
−
        <br>
+
−
        <div style="text-align: center;">
+
−
          <img alt="File:Business model.jpg" src="https://static.igem.org/mediawiki/2015/thumb/4/44/Business_model.jpg/755px-Business_model.jpg" height="600" width="755">
+
−
        </div>
+
−
      </div>
+
 
     </div>
 
     </div>
−
     <big>
+
     <p class="MsoListParagraph" style="text-indent: -18pt;">
−
<br>
+
      <br>
−
</big>&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;
+
    </p>
−
     <br>
+
     <p class="MsoListParagraph" style="text-indent: -18pt;"></p>
 
   </div>
 
   </div>
 +
  <br>
 
   <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww">
 
   <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww">
−
     <img style="border: 0px solid ; width: 150px; height: 150px; top: 35px; left: 989px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf">
+
     <img style="border: 0px solid ; width: 150px; height: 150px; left: 989px; top: 49px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf">
 
   </a>
 
   </a>
−
   <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx">
+
   <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx gwd-a-d01x">
−
     <img src="https://static.igem.org/mediawiki/2015/thumb/9/94/Logo43.png/454px-Logo43.png" class="gwd-img-l2p5">
+
     <img src="https://static.igem.org/mediawiki/2015/thumb/8/85/Logo_Definitvo.png/654px-Logo_Definitvo.png" class="gwd-img-zpsn">
 
   </a>
 
   </a>
 
   <br>
 
   <br>
 
   <br>
 
   <br>
−
   <div class="gwd-div-t5nw gwd-div-0zj6">
+
   <br>
−
    <style>
+
  <br>
−
      body {
+
   <br>
−
        font-family: Arial;
+
−
      }
+
−
      nav ul {
+
−
        list-style: none;
+
−
        padding: 0px;
+
−
      }
+
−
      nav li {
+
−
        line-height: 3rem;
+
−
        position: relative;
+
−
        width: 190px;
+
−
      }
+
−
      nav li ul {
+
−
        position: absolute;
+
−
      }
+
−
      nav a {
+
−
        color: rgb(0, 0, 0);
+
−
        display: block;
+
−
        padding: 0px 2.5em;
+
−
        text-decoration: none;
+
−
        transition: 0.3s;
+
−
        -webkit-transition: 0.3s;
+
−
      }
+
−
      nav a:hover {
+
−
        background: rgb(255, 186, 0);
+
−
      }
+
−
      nav li ul {
+
−
        display: none;
+
−
      }
+
−
      nav li:hover ul {
+
−
        display: block;
+
−
      }
+
−
      nav > ul {
+
−
        display: table;
+
−
        width: 100%;
+
−
        background: rgb(255, 166, 0);
+
−
      }
+
−
      nav > ul > li {
+
−
        float: left;
+
−
      }
+
−
      nav li li {
+
−
        max-height: 0px;
+
−
        transition: all 0.1s;
+
−
        -webkit-transition: all 0.1s;
+
−
        overflow: hidden;
+
−
        width: 200px;
+
−
        background: rgb(237, 173, 0);
+
−
      }
+
−
      nav li:hover > ul > li {
+
−
        max-height: 500px;
+
−
        overflow: visible;
+
−
      }
+
−
      nav > ul > li > ul {
+
−
        top: 100%;
+
−
      }
+
−
      .gwd-nav-nvls {
+
−
        -webkit-transform: translate3d(-13.57px, 349.01px, 0px);
+
−
        -webkit-transform-style: preserve-3d;
+
−
      }
+
−
      .gwd-div-0zj6 {
+
−
        -webkit-transform: translate3d(-8.17px, -1631.31px, 0px);
+
−
        -webkit-transform-style: preserve-3d;
+
−
      }
+
−
    </style>
+
−
    <nav class="gwd-nav-nvls">
+
−
      <ul>
+
−
        <li><a href="https://2015.igem.org/Team:San_Andres">Home</a>
+
−
        </li>
+
−
        <li><a href="https://2015.igem.org/Team:San_Andres/Team">Team</a>
+
−
        </li>
+
−
        <li><a href="https://2015.igem.org/Team:San_Andres/Description">Project</a>
+
−
          <ul>
+
−
            <li><a href="https://2015.igem.org/Team:San_Andres/Parts">Parts</a>
+
−
            </li>
+
−
            <li><a href="https://2015.igem.org/Team:San_Andres/Modeling">Modeling</a>
+
−
            </li>
+
−
            <li><a href="https://2015.igem.org/Team:San_Andres/Results">Results</a>
+
−
            </li>
+
−
          </ul>
+
−
        </li>
+
−
        <li><a href="https://2015.igem.org/Team:San_Andres/Notebook">Notebook</a>
+
−
          <ul>
+
−
            <li><a href="https://2015.igem.org/Team:San_Andres/Practices">Human Practices</a>
+
−
            </li>
+
−
            <li><a href="https://2015.igem.org/Team:San_Andres/Design">Future Projections</a>
+
−
            </li>
+
−
          </ul>
+
−
        </li>
+
−
        <li><a href="https://2015.igem.org/Team:San_Andres/Collaborations">Collaborations</a>
+
−
        </li>
+
−
      </ul>
+
−
    </nav>
+
−
   </div>
+
 
</body>
 
</body>
  
 
</html>
 
</html>

Latest revision as of 01:22, 15 September 2015

<endnote><head> <title><endnote><head> <meta> <title> wiki wiki exp wiki wiki wiki 2   File:Gluten-s-Job.jpeg

Home Team Project Parts Modeling Results
Notebook Human Practices Future Projections Attributions Collaborations

Abstract

The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.

Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.

File:Ex 2.jpg